Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.42 |
| ▸ | FADS1 | O60427 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 4/20 | 0.41 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12745282 | 0.98 | HDAC8 (0.47) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL23232067 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL30800492 | 0.91 | CA12 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL29597362 | 0.89 | CA12 (0.56) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL21905500 | 0.89 | CA12 (0.56) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL29405564 | 0.89 | HDAC8 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL10136271 | 0.89 | HDAC8 (0.54) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL22579723 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL10136282 | 0.88 | HSD17B10 (0.53) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL29407327 | 0.88 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729310-B2 | Halogenated diarylamine compound and synthesis method thereof | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8729310-B2 | Halogenated diarylamine compound and synthesis method thereof | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071317-A1 | HALOGENATED DIARYLAMINE COMPOUND AND SYNTHESIS METHOD THEREOF | DDT, NAT1, CYP1A1 | CA12 3298/4885CA1 2746/4885CA2 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.